These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29126844)

  • 21. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
    Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
    J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal prostate cryoablation: initial results show cancer control and potency preservation.
    Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC
    J Endourol; 2006 Sep; 20(9):688-92. PubMed ID: 16999628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal Cryotherapy for Localized Prostate Cancer.
    Tay KJ; Polascik TJ
    Arch Esp Urol; 2016 Jul; 69(6):317-26. PubMed ID: 27416635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry.
    Li YH; Elshafei A; Agarwal G; Ruckle H; Powsang J; Jones JS
    Prostate; 2015 Jan; 75(1):1-7. PubMed ID: 25283814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparisons of Oncological and Functional Outcomes Between Primary Whole-Gland Cryoablation and High-Intensity Focused Ultrasound for Localized Prostate Cancer.
    Liu YY; Chiang PH
    Ann Surg Oncol; 2016 Jan; 23(1):328-34. PubMed ID: 26088651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.
    Natarajan S; Raman S; Priester AM; Garritano J; Margolis DJ; Lieu P; Macairan ML; Huang J; Grundfest W; Marks LS
    J Urol; 2016 Jul; 196(1):68-75. PubMed ID: 26748164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage prostate cryoablation: initial results from the cryo on-line data registry.
    Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS
    J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Male lumpectomy": focal therapy for prostate cancer using cryoablation.
    Onik G; Vaughan D; Lotenfoe R; Dineen M; Brady J
    Urology; 2007 Dec; 70(6 Suppl):16-21. PubMed ID: 18194706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome.
    Ng CK; Moussa M; Downey DB; Chin JL
    J Urol; 2007 Oct; 178(4 Pt 1):1253-7; discussion 1257. PubMed ID: 17698104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryosurgery as primary treatment for localized prostate cancer.
    Lian H; Guo H; Gan W; Li X; Yan X; Wang W; Yang R; Qu F; Ji C
    Int Urol Nephrol; 2011 Dec; 43(4):1089-94. PubMed ID: 21475948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate.
    Cheetham P; Truesdale M; Chaudhury S; Wenske S; Hruby GW; Katz A
    J Endourol; 2010 Jul; 24(7):1123-9. PubMed ID: 20575687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective trial of regional (hockey-stick) prostate cryoablation: oncologic and quality of life outcomes.
    Gregg JR; Borregales LD; Choi H; Lozano M; McRae SE; Venkatesan AM; Davis JW; Nogueras-Gonzalez GM; Pisters LL; Ward JF
    World J Urol; 2021 Sep; 39(9):3259-3264. PubMed ID: 33454813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience.
    Woodrum DA; Kawashima A; Karnes RJ; Davis BJ; Frank I; Engen DE; Gorny KR; Felmlee JP; Callstrom MR; Mynderse LA
    Urology; 2013 Oct; 82(4):870-5. PubMed ID: 23910089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy.
    Lian H; Yang R; Lin T; Wang W; Zhang G; Guo H
    Int Urol Nephrol; 2016 Sep; 48(9):1461-6. PubMed ID: 27300004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD Registry.
    Dhar N; Ward JF; Cher ML; Jones JS
    BJU Int; 2011 Aug; 108(4):508-12. PubMed ID: 21722288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New treatments for localized prostate cancer.
    Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
    Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience.
    Barzell WE; Melamed MR
    Urology; 2007 Dec; 70(6 Suppl):27-35. PubMed ID: 18194708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal cryoablation for unilateral low-intermediate-risk prostate cancer: 63-month mean follow-up results of 41 patients.
    Lian H; Zhuang J; Yang R; Qu F; Wang W; Lin T; Guo H
    Int Urol Nephrol; 2016 Jan; 48(1):85-90. PubMed ID: 26531063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients.
    Ismail M; Ahmed S; Kastner C; Davies J
    BJU Int; 2007 Oct; 100(4):760-4. PubMed ID: 17662081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of selective nerve sparing in high risk prostate cancer during robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Bates AS; Mouraviev V; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Jun; 11(2):129-138. PubMed ID: 27435701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.